Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus
Clinical trial NCT06886126 · RECRUITING
Trial details
- NCT number
- NCT06886126
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-07
- Primary completion
- 2025-09-23
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.